Previous studies have shown PGRMC1 is induced in many different types of cancers, including breast, thyroid, colon, ovary, and lung cancers (Hampton et al., 2015), and required for the key functions of tumor growth, cancer cell survival, and motility, particularly after chemotherapeutic drugs (Cahill et al., 2016). This evidence concerns the gene PGRMC1 and cancer.